Advertisement

Topics

Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Company Profile

12:05 EDT 14th August 2018 | BioPortfolio

Minneamrita is an early clinical stage drug development company developing the molecules for unmet cancer treatments. Minneamrita is developing Minnelide for its use in various cancers (gastric, pancreatic, breast and AML).


News Articles [4784 Associated News Articles listed on BioPortfolio]

M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin

Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...

Phanes Therapeutics selects CrownBio to advance oncology drug pipeline

Global drug discovery and development services company, Crown Bioscience, has been selected as a strategic partner by Phanes Therapeutics to accelerate the discovery and development of novel oncology ...

#jobs #lifescience Celgene: Scientist II, Translational Development (Myelofibrosis)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Celgene: Scientist II, Translational Development (Myelofibrosis) . Celgene: O...

Mission Therapeutics: Yielding novel therapeutics for the benefit of patients

Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. They have built a World-leadin...

Ewing Sarcoma Pipeline Review, H1 2018 – Therapeutics Development Analyzed, Key Companies Involved and Drug Profiles Covered – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ewing Sarcoma – Pipeline Review, H1 2018” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive...

ADC Therapeutics Terminates its ADCT-502 Program Targeting HER2 Expressing Solid Tumors

LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugate...

2017 Global Hereditary Angioedema (HAE) Therapeutics Pipeline Analysis Report: by Phase, ...

The study analyzed that HAE therapeutics pipeline comprises 20 drug candidates in different stages of development. According to research findings, most of the drug candidates Read more...

FDA panels vote to reject Pain Therapeutics' abuse-deterrent opioid drug

Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory panel, which could have drastic consequences on its chances ...

PubMed Articles [5041 Associated PubMed Articles listed on BioPortfolio]

Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline.

As we witness steady progress towards the development of robust, scalable, and reproducible 3D tissue models for preclinical drug testing, there is a need for systematic physiological and pharmacologi...

On the glycosylation aspects of biosimilarity.

The recent expiration of several protein therapeutics opened the door for biosimilar development. Biosimilars are biologic medical products that are similar but not identical copies of already-authori...

Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development.

Oligonucleotide and modified mRNA therapeutics have great potential to treat diseases that are currently challenging to cure and are expanding into global and chronic disease areas such as cancer and ...

Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including Japan.

Multiregional clinical trials (MRCT) are a standard strategy used to improve global drug approval efficiency and the feasibility of clinical trials. Japan is the world's third largest drug market with...

Challenges and Opportunities With Oncology Drug Development in China.

Clinical Trials [4281 Associated Clinical Trials listed on BioPortfolio]

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis

Drug-resistant tuberculosis is becoming a major problem for the whole humanity, and development of new Anti-TB drugs is of great importance. Since Kazakhstan is a country with the high bur...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [3871 Associated Companies listed on BioPortfolio]

Translational Drug Development (TD2) and Minneamrita Therapeutics LLC

Minneamrita is an early clinical stage drug development company developing the molecules for unmet cancer treatments. Minneamrita is developing Minnelide for its use in various ca...

Neurimmune Therapeutics AG

Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with a focus on protein aggregation diseases. The cur...

Crown Bioscience, Inc.

Crown Bioscience, Inc. is a U.S.-based drug discovery service company with R&D facilities in China committed to advancing anti-cancer therapeutics through the preclinical a...

BlackThorn Therapeutics, Inc.

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and develo...

TD2

Translational Drug Development (TD2) is an oncology development organization that provides innovative services for oncology-focused biopharmaceutical companies. Using a dedicated ...

More Information about "Translational Drug Development (TD2) and Minneamrita Therapeutics LLC" on BioPortfolio

We have published hundreds of Translational Drug Development (TD2) and Minneamrita Therapeutics LLC news stories on BioPortfolio along with dozens of Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Clinical Trials and PubMed Articles about Translational Drug Development (TD2) and Minneamrita Therapeutics LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Companies in our database. You can also find out about relevant Translational Drug Development (TD2) and Minneamrita Therapeutics LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...


Corporate Database Quicklinks



Searches Linking to this Company Record